Figure 1.

Schematic illustration of the working principle of the CRISPR-powered PGM biosensing platform for quantitative detection of AFP biomarker.

Schematic illustration of the working principle of the CRISPR-powered PGM biosensing platform for quantitative detection of AFP biomarker.